BioStem Technologies, Inc. (BSEM)
OTCMKTS · Delayed Price · Currency is USD
10.40
-0.25 (-2.35%)
Aug 14, 2025, 3:57 PM EDT
BioStem Technologies Market Cap
BioStem Technologies has a market cap or net worth of $178.77 million as of August 14, 2025. Its market cap has increased by 27.32% in one year.
Market Cap
178.77M
Enterprise Value
156.40M
Revenue
332.45M
Ranking
n/a
PE Ratio
7.56
Stock Price
$10.40
Market Cap Chart
Since August 4, 2009, BioStem Technologies's market cap has increased from 4.77M to 178.77M, an increase of 3,644.47%. That is a compound annual growth rate of 25.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 178.77M | -22.42% |
| Dec 31, 2024 | 230.43M | 143.12% |
| Dec 29, 2023 | 94.78M | 160.66% |
| Dec 30, 2022 | 36.36M | 267.00% |
| Dec 30, 2021 | 9.91M | -25.50% |
| Dec 31, 2020 | 13.30M | -41.66% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.72M |
| Veradigm | 789.71M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 608.19M |
| Glass House Brands | 543.74M |
| American Oncology Network | 393.37M |
| Northwest Biotherapeutics | 332.06M |
| CytoDyn | 300.87M |